The Pfizer and BioNTech vaccines have been shown to work between the two vaccines, and the University of Oxford and AstraZeneca have published detailed test data on their vaccine that is 90 percent effective.

Coronavirus: the second wave, the second closure

Later than expected by many, but in mid-November, the Hungarian government also decided to try to curb the second wave of the coronavirus epidemic by introducing restrictions. At the time of the decision, 5,000 new infections a day had been identified and the number of deaths from the virus mostly ranged from 50 to 100 in 24 hours. The first step is a partial closure, but how effective it is is questionable. Follow our news!

The Pfizer and BioNTech vaccine already provides strong protection against Covid-19 10 days after the first vaccination, the United States Food and Drug Administration (FDA) said. THE The New York Times wrote: a month ago it was only known that after two vaccines given three to three weeks apart, the effectiveness was 95 percent, but now it turned out that the first dose worked too.

There are no serious side effects from the vaccine, at most some volunteers have reported mild pain and fever. 44,000 people requested the test, 22,000 of whom received the vaccine and 22,000 people received a placebo vaccine. Among those who received the Covid-19 vaccine, there were far fewer coronaviruses ten days later. The FDA will decide on approval Thursday based on this.

Meanwhile, there is also good news about the vaccine from Oxford University and AstraZeneca. A report has been published stating that the vaccination is 90 percent safe and effective. THE The lancetAccording to data presented in one of the world’s leading medical journals, 90 percent efficacy was measured when test subjects were given half a dose first and then a full dose a second time. When they received two full doses, the effectiveness was only 62 percent. THE The independent added to this: this is also an extremely important event because it was the first time such detailed test data had been published in a medical journal.

If you want to know about similar things at other times, you will like the HVG Tech Facebook page, which also offers scientific news.



The number of independent power editorial boards is steadily declining, and those that still exist are trying to stay afloat in a growing headwind. At HVG we persevere, we do not give in to pressure and we bring national and international news every day.

That is why we ask you, our readers, to support us, support us, join our membership and renew it.

And we promise to continue to do our best for you in all circumstances!

Béla Merkely: Vaccination will not start with Russian vaccine



hvg.hu
At home

Nor should the power of epidemiological measures disappear at Christmas, warned the rector of the University of Semmelweis.

A 90-year-old British woman is vaccinated for the first time in the world with the Pfizer / BioNTech 95% vaccine



hvg.hu
Technology

Margaret Keenan is the first British citizen to receive the Pfizer / BioNTech vaccine, which is already widely used in the island nation.